Introduction
In the Hokuriku region of Japan, atopic cough (AC), cough variant asthma (CVA), and sinobronchial syndrome (SBS) are the major causes of chronic cough. However, airway malignant tumors cause persistent cough, and missed or delayed diagnosis of malignancy may result in serious consequences. We report the case of a 31-year-old man who was finally diagnosed with bronchial carcinoid and AC after suffering from a chronic non-productive cough for 6 months.
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Case Report
A 31-year-old man, working as a fisherman, visited his family doctor after a 6-month history of non-productive cough. He also reported a few episodes of yellow sputum and post nasal drip within a month, which spontaneously resolved without treatment.
This non-productive cough worsened at night and was accompanied by itching in the throat. His cough appeared to resolve for brief periods following symptomatic treatment but then returned. He was referred to our hospital for further treatment. He was a current smoker. His past medical history included perennial and seasonal allergic rhinitis and chronic sinusitis as a child. There was no history of either chronic cough and bronchial asthma or angiotensinconverting enzyme (ACE) inhibitor use. His family history was not clinically significant.
At the initial visit, his vital signs were stable, with a body temperature of 36.8°C and hemoglobin oxygen saturation of 98%. Auscultation of the chest was normal. Chest and sinus X-rays were normal ( Figure 1 ).
His peripheral WBC count was 6,200/µl, with 55.6% neutrophils and 1.1% eosinophils. Serum C-reactive protein level was 0.0 mg/dl. Total serum IgE level was 143 IU/mL, and antigen-specific IgE against house dust mite (Dermatophagoides farina), cedar pollen, ragweed pollen, timothy pollen, and Anthoxanthum odoratum pollen were positive.
The pulmonary function tests demonstrated no evidence of restrictive or obstructive ventilatory impairments, and no bronchial reversibility (%FVC, 118.3%; %FEV1, 117.8%; FEV1/FVC ratio, 91.1%; bronchial reversibility, 140 mL, 3.3%). Sputum for cytology and detection of pathogens could not been obtained. His cough was resistant to the bronchodilator therapy (40 µg/day oral clenbuterol for 10 days). Next, he was administered two puffs per day of 200 µg fluticasone propionate inhaler, which is an inhaled corticosteroid, and azelastine, which is a histamine H1 antagonist. After initiating inhaled corticosteroids, his cough almost but not completely resolved. Therefore, chest computed tomography (CT) was performed, which revealed an endobronchial tumor in the left main bronchus (Figures 2a and 2b ). To reduce procedure-related hemorrhage, a hot biopsy was performed. The biopsy specimen showed that the tumor cells had round to oval nuclei and the eosinophilic cytoplasm formed a focal and trabecular pattern.
No mitosis or necrosis was present. Tumor cell polymorphism was hardly observed after H&E staining (Figures 4a and 4b ). The tumor presented positive immunoreactivity for chromogranin-A ( Figure 4c ), synaptophysin ( Figure 4d ).
Typical carcinoid was the final clinical diagnosis. He successfully underwent resection of the tumor and left main bronchus and subsequently bronchoplasty. There was no metastasis in the seven dissected mediastinal lymph nodes. The final pathological examination of the surgical specimen confirmed complete resection of the endobronchial-typical carcinoid from the left main bronchus. There were no complications during the postoperative period, and the patient was discharged from the hospital 10 days after the operation. The histamine H1 antagonist and inhaled corticosteroids were discontinued after several days of complete resolution of his nonproductive dry cough. Five years after surgical treatment, the patient was well, had no cough, and was asymptomatic with no signs of carcinoid recurrence. 
Discussion
Chronic cough has been defined as a "cough (as the only symptom) lasting for >8 weeks and with a cause that is not apparent by physical examination and routine testing such as CXR and spirometry" [1] . In the Hokuriku region of Japan, AC, CVA, and SBS are major causes of chronic cough [2] .
Because both AC and CVA present with non-productive cough and eosinophilic inflammation of the airways, it is difficult to distinguish AC and CVA in daily clinical practice. According to the Japanese Guidelines on Cough, "therapeutic diagnosis with bronchodilators" is useful for distinguishing between CVA and AC [1] .
In CVA, the fundamental physiological feature is a heightened cough response to bronchoconstriction [3] , and bronchoconstrictiontriggered cough usually responds well to bronchodilators such as beta-2 stimulants.
In contrast, in AC, enhanced sensitivity of cough receptors in the airway superficial layer is the fundamental feature, and AC does not respond to bronchodilators. Therefore, it is possible to make a diagnosis of CVA if cough disappears or is alleviated following 1-2 weeks of treatment with a bronchodilator.
AC responds to histamine H1 antagonist and inhaled corticosteroid therapy. SBS presenting with productive cough manifests as chronic sinusitis and chronic neutrophilic inflammation of the lower airways such as chronic bronchitis, diffuse bronchiectasis, and diffuse panbronchiolitis [4] . We diagnosed AC in our patient because his bronchodilator-resistant cough was almost resolved with histamine H1 antagonist and inhaled corticosteroids.
In our case, his non-productive cough was resistant to 10-day bronchodilator therapy. Furthermore, cough was almost resolved by inhaled corticosteroids. The Japanese Guidelines on Cough list the differential diagnosis of prolonged and chronic non-productive cough (apart from AC and CVA) as follows: ACE inhibitor-induced cough, gastroesophageal reflux-associated cough, post-infectious persistent cough, pertussis, chlamydia infection, mycoplasma infection, eosinophilic bronchitis without asthma, laryngeal allergy, chronic interstitial pulmonary disease, psychogenic/habit cough, tracheobronchial tuberculosis, endobronchial foreign body, and endobronchial malignancy [1] .
Chest CT is performed to distinguish among malignancy, tuberculosis, and interstitial pulmonary disease, which can be lifethreatening in some cases. We have showed that 11.5% of patients with chronic cough had dual cough causing disease in the Hokuriku region of Japan [2] . In our case, AC and endobronchial carcinoid were causes of chronic cough and therefore remaining cough with histamine H1 antagonist and inhaled corticosteroids completely relieved after the resection of endobronchial-typical carcinoid from the left main bronchus. In atopic cough, antitussive medication is generally stopped after the complete resolution of cough and so-called maintenance therapy is not recommended [1] . Thus, a final diagnosis of AC and endobronchial-typical carcinoid was given as the cause of the chronic non-productive cough.
Bronchopulmonary carcinoid tumors are rare, comprising 1%-2% of all bronchopulmonary tumors [5] and approximately 25% of all carcinoid tumors [6] . Carcinoid tumors are classified according to their pathological features as either typical carcinoid (TC, <2 mitoses/2 mm 2 of viable tumor) or atypical carcinoid (ATC, 2-10 mitoses, necrosis, or architectural disruption) [7] . TC is 8-10 folds more frequent than ATC and is typically present in younger patients between the 4th and 6th decades of life [8] [9] [10] . Seventy-five percent of bronchopulmonary carcinoid tumors are located in the central airways [11] . The left main bronchus accounts for 8% of central tumors [12] . Most TCs occur in the central airway and often produce symptoms as a result of partial or complete bronchial obstruction or because of its high vascularity.
Symptoms of bronchopulmonary carcinoid tumors include cough, hemoptysis, wheezing, recurrent pulmonary infection, obstructive pneumonia, and/or atelectasis. Five percent of bronchopulmonary carcinoid tumors have a normal chest roentgenogram, as observed in our case. Even when respiratory symptoms are present, the diagnosis of bronchopulmonary carcinoid tumors is often delayed [13] .
Several studies have demonstrated that lung cancer is the cause of chronic cough in ≤2% of cases. Among the differential diagnosis of chronic cough, the percentage of cases with endobronchial malignancy appears to be low; however, physicians should not eliminate the Recently, a large-scale cohort study using the Internet to investigate the prevalence of cough in the general population in Japan revealed a prevalence of chronic cough of >2% (>2.5 million individuals). Cough has a negative effect on the quality of life [14] . We need to determine the differential diagnosis of the causative disease causing the cough with medical history taking and physical and clinical examinations. The appropriate differential diagnosis leads to a disease-specific therapy, for example, histamine H1 antagonist for AC or bronchodilator for CVA. If disease-specific therapy for treating the suspected cough-causing disease is insufficient, then we should be cognizant of the existence or coexistence of another underlying disease.
